S
Sabine Altrichter
Researcher at Charité
Publications - 94
Citations - 3070
Sabine Altrichter is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Omalizumab. The author has an hindex of 24, co-authored 67 publications receiving 2164 citations. Previous affiliations of Sabine Altrichter include Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Marcus Maurer,Sabine Altrichter,Thomas Bieber,Tilo Biedermann,Matthias Bräutigam,Stefan Seyfried,Randolf Brehler,Jürgen Grabbe,Nicolas Hunzelmann,Thilo Jakob,Andreas Jung,Jörg Kleine-Tebbe,Martin Mempel,Michael Meurer,Kristian Reich,Franziska Ruëff,Knut Schäkel,Kaushik Sengupta,Christian Sieder,Jan C. Simon,Bettina Wedi,Torsten Zuberbier,Vera Mahler,Petra Staubach +23 more
TL;DR: The results of this study indicate that omalizumab is an effective treatment option for patients with CU with IgE autoantibodies against TPO who are refractory to conventional treatment.
Journal ArticleDOI
The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision
Markus Magerl,Sabine Altrichter,Elena Borzova,A. Giménez-Arnau,Clive Grattan,F. Lawlor,P. Mathelier-Fusade,R. Y. Meshkova,T. Zuberbier,Martin Metz,Marcus Maurer +10 more
TL;DR: These recommendations for the definition, diagnosis and management of chronic inducible urticaria (CIndU) extend, revise and update the previous consensus report on physical urticarias and cholinergic uricaria (Allergy, 2009), and acknowledge the latest changes in understanding of CIndU.
Journal ArticleDOI
IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria?
Sabine Altrichter,Hans-Jürgen Peter,Dina Pisarevskaja,Martin Metz,Peter Martus,Marcus Maurer +5 more
TL;DR: The findings show that a sizeable subgroup of csU patients expresses IgE antibodies against thyroid peroxidase, which could cause "autoallergic" mast cell activation, a novel pathomechanism of chronic spontaneous urticaria.
Journal ArticleDOI
Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria
Janine Gericke,Martin Metz,Tatevik Ohanyan,Karsten Weller,Sabine Altrichter,Per Stahl Skov,Sidsel Falkencrone,Janko Brand,Arno Kromminga,Tomasz Hawro,Martin K. Church,Marcus Maurer +11 more
Journal ArticleDOI
Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria.
Martin Metz,Sabine Altrichter,E. Ardelean,Birgit Kessler,Karoline Krause,Markus Magerl,Frank Siebenhaar,Karsten Weller,Torsten Zuberbier,Marcus Maurer +9 more
TL;DR: The overall excellent responses to omalizumab treatment reported here indicate that anti-immunoglobulin E is a safe and effective treatment for recalcitrant physical urticarias.